Cheshire ADHD and Autism Services

ADHD diagnostic assessment

The ADHD Team provides assessment to children and young people aged 6-16 years who have a GP in Cheshire East. The team accepts referrals for children and young people who have not received a previous diagnosis of ADHD.

ADHD treatment and medication monitoring

This service is available to children and young people aged 6-16 years who have received a diagnosis of ADHD and have a GP in Cheshire East.

ASC diagnostic assessment

The ASC Team provides assessment to children and young people aged 4-18 years and who have a GP in Cheshire East, and to children and young people aged 11-16 years and who have a GP in Cheshire West. This does not include children and young people who access health services from Winsford, Northwich, Bunbury, Frodsham or Helsby practices (unless they live in Elton). The Team accepts referrals for children and young people who have not received a previous diagnosis of ASC.

ADHD and Autism Assessment Service Providers

For Cheshire West please refer via the Community Paediatric Service

For Cheshire East referrals are made online via the online referral form on this page. 

ADHD areas covered

• East Cheshire – age 6-16 years
  • Poynton
  • Wilmslow
  • Macclesfield
  • Knutsford
  • Congleton
  • Holmes Chapel

Details of other providers for ADHD

• West Cheshire – age 6-16 years 
  • Community Paediatric team via Kingsway Children’s Centre Kingsway Chester CH2 2LB.   
  • 01244 366724
  • https://www.livewell.cheshirewestandchester.gov.uk/Services/301/Community-Paediatric
• East and West Cheshire – age 16+
  • Adult ADHD team
  • 0300 303 3157
  • cwp.adhdreferrals@nhs.net

ASC areas covered

• East Cheshire – age 4-18 years
  • Poynton
  • Wilmslow
  • Macclesfield
  • Knutsford
  • Congleton
  • Holmes Chapel

Details of other providers for ASC

• West Cheshire – age 0-16 years 

• • Community Paediatric team via Autism Coordinator, Kingsway Children’s Centre Kingsway Chester CH2 2LB. 
  • 01244 366724
  • www.livewell.cheshirewestandchester.gov.uk/Services/301/Community-Paediatric

• East Cheshire – age 18+
• West Cheshire – age 16+
  • Adult ASD service
  • 01244 397640
  • cwp.adultautismreferrals@nhs.net

SEND Partnership briefing on ADHD and ASC (North) East Cheshire

East Cheshire  ADHD  transition process to adult services

There are supply disruptions affecting various strengths of the following medications which are licensed for the treatment of attention deficit hyperactivity disorder (ADHD): 

• Methylphenidate:* 

Equasym XL® 10, 20 and 30 mg capsules 

Xaggitin XL® 18 and 36 mg prolonged-release tablets 

Concerta XL® 54 mg prolonged-release tablets 

Xenidate XL® 27 mg prolonged-release tablets 

• Lisdexamfetamine: 

Elvanse® 20, 30, 40, 50, 60 and 70 mg capsules 

Elvanse® Adult 30, 50, and 70 mg capsules 

• Guanfacine: 

Intuniv® 1, 2, 3 and 4 mg prolonged-release tablets 

At present, the supply disruptions are expected to resolve at various dates between October and December 2023 

• Atomoxetine: 

The Department of Health and Social Care (DHSC) issued a Medicine Supply Notification in August 2023 for the shortage of atomoxetine capsules. The supply issue with atomoxetine is set to resolve in October 2023. 

The supply disruption of these products is caused by a combination of manufacturing issues and an increased global demand. 

The following medications, also commonly used to treat ADHD, continue to be in good supply.

Methylphenidate immediate release tablet:

• Tranquilyn
• Ritalin
• Medikinet

Methylphenidate (8-hour release):

• Medikinet XL prolonged release capsules

Methylphenidate prolonged release tablets (12-hour release):

• Matoride XL
• Delmosart XL
• Affenid XL (these can be used as a direct replacement for affected strengths of Concerta Xl, Xenidate XL, Xaggitin XL)